The maximum allowable direct costs for the entire period of performance are $2.5M plus indirect costs.

 

All direct and indirect costs of any subaward (subgrant or subcontract) must be included in the total direct costs of the primary award.

his/her creativity, innovation, and leadership on ovarian cancer research.  This individual must have experience in guiding a research team and demonstrate that he/she is committed to investigating paradigm-shifting ideas in ovarian cancer.  The Teal Innovator Award will provide the Principal Investigator (PI) with the funding and freedom to pursue his/her most novel, visionary, high-risk ideas that could significantly impact the field of ovarian cancer research or patient care.  The proposed Teal Innovator must be highly recognized in his/her field and present evidence of this recognition.  Examples include, but are not limited to, recognition at the level of endowed chair, membership in the Institute of Electrical & Electronics Engineers, National Academy of Sciences, National Academy of Engineering, or Institute of Medicine, or other national or international recognition.